Unknown NA INTERVENTIONAL 2-arm NCT04623619

Efficacy and Safety of Acetyl L-Carnitine in COVID-19 Patients With Mild-to-Moderate Disease

Use of Acetyl L-Carnitine in Patients With Covid-19 Pneumonia

Sponsor: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

Conditions Covid19

Updated 5 times since 2020 Last updated: Nov 15, 2020 Started: Dec 15, 2020 Primary completion: Apr 29, 2021 Completion: Jul 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Covid19, this trial is ongoing. The trial is conducted by Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo and has accumulated 5 data snapshots since 2020. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Dec 2022 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Dec 2022 [monthly]

Not Yet Recruiting NA
Dec 2020 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

Data source: Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.